Searchable abstracts of presentations at key conferences in endocrinology

ea0015s5biog | The British Thyroid Association Pitt Rivers Lecture | SFEBES2008

The British Thyroid Association Pitt Rivers Lecture

Cheng Sheue-yann

Sheue-yann Cheng, Gene Regulation Section, National Institutes fo Health, Bethesda, MD, USA AbstractSheue-yann Cheng, PhD, is the chief of the Gene Regulation Section, Laboratory of Molecular Biology, National Cancer Institute (NCI), National Institutes of Health (NIH) and an advisor for women scientists at the Center for Cancer Research, NCI. She is on the editorial boards of Thyroid, Endocrinology, and Expert Revi...

ea0094p381 | RET | SFEBES2023

RET inhibitors in thyroid cancer: A single-institution experience

Cheng Leslie , Hoy Sonja , Hyer Stephen , Morganstein Daniel , Kim Dae , Howe Wong Kee , Newbold Kate

Background: Mutations in the RET proto-oncogene occur in about 70% of medullary thyroid cancers (MTC) and is central in its pathogenesis. Two highly selective RET inhibitors, selpercatinib and pralsetinib, are FDA/EMA-approved in RET-altered thyroid cancers. We share our experience of these drugs in metastatic MTC.Methods: Data were collected retrospectively from 19 patients commenced on selective RET inhibitors for MTC ...

ea0019s35 | Phosphoinositide 3-kinase (PI3K) signalling in health and disease: an old system with new potential | SFEBES2009

Disordered phosphoinositide signalling and the basis of tumour formation

Leslie Nick

Almost all tumours display increased activity of components of the phosphoinositide 3-kinase (PI3K) signalling pathway. In particular, activating mutations in the PI3K catalytic subunit, p110alpha, and loss of function mutations of the opposing PTEN phosphatase are amongst the most frequent alterations in human cancers. Our current work aims to understand how loss of PTEN function contributes to tumour development through two related projects. Firstly, we are attempting to add...

ea0099p122 | Pituitary and Neuroendocrinology | ECE2024

Cushing’s syndrome: normalization of cortisol is just the beginning

Jordan Gretchen , Edwin Leslie

Introduction: Cushing’s Syndrome is caused by elevated levels of cortisol and is characterized by dozens of non-specific physical, metabolic, and neuropsychological symptoms. The extent of damage a patient will face is directly related to time to diagnosis, experience of the doctors and surgeon, and the support and education they receive after surgery. The spectrum of long-term needs faced by patients who have been exposed to prolonged elevated cortisol are not well repre...

ea0031s7.4 | Thyroid hormone receptors – mutations and implications (Supported by <emphasis role="italic">Journal of Molecular Endocrinology</emphasis>) | SFEBES2013

Nuclear receptor corepressors confer the actions of mutant thyroid hormone receptor α

Cheng Sheue-yann

Patients with mutations of the thyroid hormone receptor α (THRA) gene display classic features of hypothyroidism with growth and developmental retardation, skeletal dysplasia, and severe constipation, but with only borderline-abnormal thyroid hormone levels. These patients are heterozygotes, indicating that TRα1 mutants act in a dominant negative manner to mediate the clinical manifestations in these patients. However, the molecular mechanisms by which these...

ea0015s5 | The British Thyroid Association Pitt Rivers Lecture | SFEBES2008

Thyroid hormone receptors, mutations, and cancer development

Cheng Sheue-Yann

The thyroid hormone receptors (TRs) are ligand-dependent transcription factors regulating growth, development, and differentiation. That TRs are cellular homologs of the retroviral v-erbA oncogene suggests their possible involvement in carcinogenesis. Recent studies showed altered expression of TRs at both the mRNA and protein levels and identified somatic mutations of TRs in several human cancers, including thyroid carcinomas. We have created a knockin mutant mouse by targeti...

ea0077p220 | Neuroendocrinology and Pituitary | SFEBES2021

Multiple Cell Line Pituitary Adenoma associated with PIT-1 and TPIT lineage cells resulting in acromegaly with ACTH dependent Cushing’s: a case report

Joshi Hareesh , Ye Kyaw , Bridges Leslie , Martin Andrew , Bano Gul

Introduction: Anterior pituitary cells are characterised by functional lineages based on the expression pattern of transcription factors. Functional differentiation in the form of pituitary adenomas co-secreting ACTH and growth hormone is very rare. We report a case of multiple cell line pituitary adenoma resulting in acromegaly and ACTH dependent Cushing’s.Case: A 52-year-old woman of Ghanian origin (BMI of 57.5 kg/m2) presented with pro...

ea0038p344 | Pituitary | SFEBES2015

The aggressive clinical course of silent corticotroph pituitary adenomas: a case series

Beebeejaun Mehjabeen , Chinnasamy Eswari , Rich Philip , Bridges Leslie , Bano Gul

Silent corticoptroph adenomas (SCA) are pituitary tumours positive on immunohistochemical staining for ACTH but without clinical evidence of hypercortisolism. They account for 1.1–6% of surgically removed pituitary adenomas. Most tumours are macroadenomas with suprasellar extension present in 87–100% of the cases. They present with mass effects and this is in contrast to Cushing’s disease, which is mostly attributed to microadenomas. Reports suggest that these t...

ea0032p1131 | Thyroid cancer | ECE2013

Well differentiated thyroid-type carcinoma arising from struma ovarii a report of two cases

Barrera Jerome , Lina Lantion-Ang Frances , Quiwa Leslie

We report two rare cases of well differentiated thyroid-type carcinoma arising from struma ovarii managed in our institution.Case 1: A 41-year-old female admitted due to abdominal pain and vomiting. Her abdomen was globular with palpable vague mass on lower abdomen. Ultrasound scan revealed 12.5×12.1×8.3 cm heterogenous mass with ascites. Total abdominal hysterectomy with bilateral salphingo-oophorectomy was done and histopathology results reve...

ea0021p266 | Pituitary | SFEBES2009

Cabergoline therapy is associated with successful abolition of abnormal cycles of excess steroid excretion in a case of pituitary dependent Cushing’s disease

Graham Una , Mullan Karen , Leslie Hiliary , Ellis Peter , Atkinson A Brew

A 27 years old girl presented with weight gain, hirsutism, fatigue, bruising and striae. On examination she was Cushingoid. On initial assessment, 3 out of 4 24 h urinary free cortisol collections were elevated. 0800 h serum cortisol was 280 nmol/l after 1mg dexamethasone given at 2300 h. After formal 48 h low and high dose dexamethasone suppression tests cortisols were 164 and 34 nmol/l respectively. Basal 0800 h ACTH was 33 ng/l. Given the clinical features and the discrepan...